Sunday, June 10, 2012. Neuroblastoma Immunotherapy by Paul M. Sondel, MD, PhD. Sondel, MD, PhD We are pursuing basic, preclinical and clinical mechanisms to induce in vivo activated innate immune effector cells to provide anti-tumor benefit. Thursday, September 29, 2011. COG, Apeiron to conduct APN301 trial in neuroblastoma patients. APN301 is a recombinant fusion protein consisting of the humanized anti-GD2 monoclonal antibody hu14.

Sunday, May 13, 2012. Blessings for Braden Boozer BBQ Benefit. Dacula High School Practice Football Field.

DFMO is an interesting drug, and one that is currently being considered for a future clinical trial in Canada for children with neuroblastoma. There is a great deal to understand about this drug both in how it works and the process for opening up a clinical trial in Canada. MIBG Therapy for High-Risk Neuroblastoma.

Attività clinico biologica e ricerca traslazionale. Ricerca di Base e Traslazionale. Dona una storia alla ricerca. 8230; mi chiamo Wolfgang. Oltre 19 milioni di euro alla ricerca. Inserisci la tua email, resta sempre in contatto con noi.

Fundraising pages of Little Heroes. Fundraising pages of Little Heroes. Your SMH Half Marathon challenge! .